Penumbra Quarterly Balance Sheet
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Penumbra financial position
As of Jun 30, 2026, Penumbra reported total assets of $1.97 billion, up 17.9% from a year earlier against total liabilities of $444.0 million. Shareholders' equity stood at $1.53 billion, or 77.5% of assets. The company held $205.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.75, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Penumbra balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 205.27M | 241.29M | 186.90M | 321.03M | 421.77M | 376.05M | 324.40M | 280.48M | 288.33M | 223.11M | 167.49M | 100.76M |
| Short-Term Investments | 453.52M | 374.37M | 357.92M | 149.27M | 2.79M | 2.79M | 15.73M | 10.55M | 51.36M | 90.36M | 121.70M | 148.10M |
| Receivables | 190.41M | 183.29M | 190.02M | 183.43M | 175.54M | 167.98M | 167.67M | 176.05M | 200.83M | 191.99M | 201.77M | 206.62M |
| Inventory | 442.65M | 438.54M | 431.55M | 432.37M | 427.63M | 415.86M | 406.74M | 393.41M | 373.80M | 398.37M | 388.02M | 374.25M |
| Total Current Assets | 1.34B | 1.28B | 1.22B | 1.14B | 1.07B | 999.71M | 951.13M | 891.75M | 943.79M | 935.02M | 915.40M | 868.48M |
| Property, Plant & Equipment | 146.72M | 134.06M | 117.44M | 97.73M | 84.83M | 72.47M | 62.64M | 59.92M | 57.71M | 75.74M | 72.69M | 65.63M |
| Goodwill | 166.52M | 166.59M | 166.75M | 166.75M | 166.75M | 166.12M | 165.83M | 166.35M | 166.05M | 166.10M | 166.27M | 165.95M |
| Intangible Assets | 5.74M | 5.95M | 6.19M | 6.37M | 6.55M | 6.47M | 6.51M | 6.92M | 6.96M | 68.42M | 71.06M | 73.45M |
| Total Assets | 1.97B | 1.90B | 1.83B | 1.74B | 1.67B | 1.59B | 1.53B | 1.48B | 1.53B | 1.58B | 1.56B | 1.47B |
| Accounts Payable | 44.73M | 43.66M | 34.74M | 29.82M | 28.12M | 31.15M | 31.33M | 33.15M | 32.82M | 32.45M | 27.16M | 28.00M |
| Total Current Liabilities | 233.78M | 211.73M | 183.13M | 169.60M | 157.76M | 158.63M | 158.34M | 153.19M | 150.99M | 152.80M | 151.14M | 145.08M |
| Total Liabilities | 443.96M | 424.63M | 398.92M | 385.67M | 380.86M | 380.43M | 382.25M | 374.84M | 373.33M | 376.31M | 377.36M | 364.24M |
| Shareholders' Equity | 1.53B | 1.47B | 1.43B | 1.36B | 1.29B | 1.21B | 1.15B | 1.10B | 1.16B | 1.20B | 1.18B | 1.10B |
| Retained Earnings | 305.09M | 270.27M | 237.69M | 190.35M | 144.50M | 99.23M | 60.00M | 26.01M | 85.66M | 145.86M | 134.86M | 80.64M |
| Net Cash (Debt) | 658.79M | 615.66M | 544.82M | 470.30M | 424.56M | 378.85M | 340.13M | 291.02M | 339.69M | 313.47M | 289.19M | 248.85M |
| Shares Outstanding | — | — | 39.23M | — | — | — | 38.49M | — | — | — | 38.68M | — |
This table shows 12 quarterly periods of Penumbra's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PEN's reporting calendar. What is a balance sheet?